TOP STORIES

• BUSINESS Japan Drug Makers Moving to Support War-Hit Ukraine
  March 10, 2022

• BUSINESS Double-Digit Slashes to Hit 44 Major Drugs in 2022 Price Revision: Top 5 Product Poll
  March 9, 2022

• REGULATORY MHLW Publishes Brand-by-Brand Supply Status for 130 APIs Subject to Its Restriction Lifting Request
  March 9, 2022

• ORGANIZATION Apply Only Market Price-Linked Rules in Next Off-Year Revision, No Hasty Debate for Adjustment Rate: JMA Official
  March 8, 2022

• BUSINESS SanBio’s Sakigake Cell Therapy Finally Filed in Japan for Traumatic Brain Injury
  March 8, 2022

• BUSINESS Eisai Suffers 9%-Plus Cut, Sumitomo Dainippon Over 8% in 2022 Drug Price Revision: Jiho Poll
  March 7, 2022

• REGULATORY Takecab Faces 15.8% Slash, GLP-1s 11.1% in FY2022 Drug Price Revision
  March 4, 2022

• REGULATORY Outgoing Chair of Unapproved Drug Council Boasts 300 Approvals Achieved to Cut Lag, Urges New Reimbursement Scheme
  March 4, 2022

• BUSINESS AZ Japan Working towards 100% Electric Vehicle Fleet by 2025, but Challenges Remain
  March 3, 2022

• REGULATORY Alexion’s Bleeding Antidote Up for PAFSC Discussion Again after Data Integrity Issues
  March 3, 2022

• BUSINESS Zogenix Sees Its Pipeline Drugs Continue to Be Developed in Japan after UCB Deal
  March 2, 2022

• BUSINESS Drugs Might Get Hit by SWIFT Ban on Russia Even If Exempted from Trade Sanctions
  March 1, 2022

• BUSINESS Ono Sues AstraZeneca over PD-L1 Patent, Seeks 32 Billion Yen in Damage
  March 1, 2022

• REGULATORY MHLW Approves Label Expansions for Retevmo, Keytruda, Lenvima and More
  February 28, 2022

• ORGANIZATION Impact of Ukraine Invasion Limited in Japan? Trader Group Says Epirubicin Is Only API Possibly Affected
  February 25, 2022

• BUSINESS Tokyo Court Rejects Chugai’s Claim over Edirol Substance Patent
  February 25, 2022

• BUSINESS Medicago’s COVID-19 Vaccine Approved in Canada
  February 25, 2022

• ORGANIZATION Chuikyo Payer Rep Wants Category-Based Debate on Adjustment Rate, Prods PMP Cuts in Next Off-Year Revision
  February 24, 2022

• BUSINESS Bayer Gets Eylea Biosame Approval in Japan as It Braces for Biosimilar Debuts
  February 22, 2022

• BUSINESS Sleep Inducer Recalls by Fuji Yakuhin, Tatsumi Kagaku Tied to Tokyo Wholesaler’s Fake API Case
  February 21, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 76
• 77
• 78
• 79
• 80
• 81
• 82
• 83
• 84
• …
• Next ›
• 最終 »